Exploring the mechanism of action of Huoxue Quyu San hot package in intervening in sequelae of pelvic inflammatory disease based on network pharmacology and molecular docking

Hao Wang , Yuelin Huang , Yongfen Ding , Min Min , Haoran Li , Ruolan Zhang , Suyang Ma , Haoxiang Li , Xinrui Men , Liqun Yu

Intelligent Pharmacy ›› 2026, Vol. 4 ›› Issue (3) : 251 -259.

PDF (5586KB)
Intelligent Pharmacy ›› 2026, Vol. 4 ›› Issue (3) :251 -259. DOI: 10.1016/j.ipha.2026.04.006
Full length article
Exploring the mechanism of action of Huoxue Quyu San hot package in intervening in sequelae of pelvic inflammatory disease based on network pharmacology and molecular docking
Author information +
History +
PDF (5586KB)

Abstract

Objective: To investigate the therapeutic mechanism of Huoxue Quyu San Reyan Bao in treating sequelae of pelvic inflammatory disease (SPID) using network pharmacology and molecular docking.

Methods: Active components and targets of Huoxue Quyu San were obtained from TCMSP, HERB, and UniProt. SPID-related targets were retrieved from GeneCards and OMIM. Common targets were identified via Venny 2.1.0, and a herb-component-target-pathway-disease network was constructed using Cytoscape 3.10.0. A PPI network was built using STRING to screen core targets. GO and KEGG enrichment analyses were performed using DAVID. Molecular docking was conducted using AutoDock Vina 1.5.7 to validate binding affinities.

Results: A total of 170 active components and 154 common targets were identified. Key components included quercetin, apigenin, baicalein, luteolin, and daidzein. Core targets were AKT1, TNF, IL-6, INS, IL-1β, and TP53. Involved pathways included cancer, TNF, PI3K-Akt, AGE-RAGE in diabetic complications, IL-17, lipid/atherosclerosis, C-type lectin receptor, and fluid shear stress/atherosclerosis pathways. Molecular docking showed strong binding affinities.

Conclusions: Huoxue Quyu San treats SPID by modulating TNF, PI3K-Akt, and AGE-RAGE pathways, exerting anti-inflammatory, antioxidant, microcirculation-improving, and apoptosis-inducing effects.

Graphical abstract

Keywords

Huoxue Quyu San / Hot Package / Sequelae of pelvic inflammatory disease Inflammation / Network pharmacology / Molecular docking

Cite this article

Download citation ▾
Hao Wang, Yuelin Huang, Yongfen Ding, Min Min, Haoran Li, Ruolan Zhang, Suyang Ma, Haoxiang Li, Xinrui Men, Liqun Yu. Exploring the mechanism of action of Huoxue Quyu San hot package in intervening in sequelae of pelvic inflammatory disease based on network pharmacology and molecular docking. Intelligent Pharmacy, 2026, 4 (3) : 251-259 DOI:10.1016/j.ipha.2026.04.006

登录浏览全文

4963

注册一个新账户 忘记密码

1 Introduction

Sequelae of pelvic inflammatory disease (SPID) refers to a series of long-term complications resulting from pelvic inflammatory disease(PID) that has not been treated promptly or in accordance with standard guidelines. SPID often leads to fallopian tube stenosis, tubo-ovarian abscess, and chronic pelvic pain. Its clinical manifestations typically include pain in the lower abdomen and lumbosacral region, increased vaginal discharge, infertility, and ectopic pregnancy, which severely impact the quality of life of women of reproductive age.1 Among sexually active women of childbearing age (18–44 years), the prevalence of PID is approximately 4.4%. These women have about twice the risk of infertility and more than four times the risk of chronic pelvic pain compared to the general reproductive-aged female population.2,3 In a cohort of 100,000 women aged 20 to 24 with pelvic inflammatory disease, an estimated 8,550 cases of ectopic pregnancy, 16,800 cases of infertility, and 18,600 cases of chronic pelvic pain are predicted to occur,4 all of which are typical clinical manifestations of SPID. In conventional medicine, the primary treatment approach for SPID is anti-biotics. However, long-term antibiotic use can lead to drug resistance and has certain limitations in chronic disease management and relapse prevention.5,6 In recent years, external therapies in traditional Chinese medicine (TCM) have become increasingly prevalent and have demon-strated unique advantages in the treatment of SPID.7

The Huoxue Quyu San Hot Package (Blood-Activating and Stasis-Removing Hot Package) is derived from the empirical traditional Chinese medicine gynecological formula Xiaozheng San.8 It is composed of 18 medicinal herbs: Homalomena occulta, Angelica dahurica, Illicium verum, Phryma leptostachya, Dipsacus asper, Saposhnikovia divaricata, Periploca sepium, Artemisia argyi, Taxillus chinensis, Notopterygium incisum, Zanthoxylum bungeanum, Angelica biserrata, Carthamus tinctorius, Angelica sinensis, Paeonia lactiflora, Resina Draconis, Boswellia carterii, and Commiphora myrrha. In clinical application, The Huoxue Quyu San Hot Package has demonstrated significant therapeutic efficacy for SPID. However, the precise mechanism of action remains to be fully elucidated.

In recent years, with the development of systems biology and computer-aided drug design, network pharmacology and molecular docking techniques have become essential tools for investigating the mechanisms of action of traditional Chinese medicine formulas. Network pharmacology can reveal the synergistic characteristics of multi-component, multi-target, and multi-pathway actions of TCM from a holistic perspective, aligning with the holistic diagnostic and thera-peutic principles of TCM. Meanwhile, molecular docking techniques can further predict the binding modes and affinities between active components and key targets, providing a structural biology basis for preliminary validation of pharmacodynamic mechanisms. Therefore, incorporating the above techniques into the study of the mechanism of Huoxue Quyu San in the treatment of SPID can help rapidly identify core components and key targets, thereby offering theoretical clues for sub-sequent experimental validation and clinical translation.

Therefore, this study employs network pharmacology and molecular docking techniques to investigate the active components and potential mechanisms of Huoxue Quyu San Hot Package in the treatment of SPID, aiming to provide a theoretical basis for its clinical application. The research findings are reported as follows.

2 Materials and methods

2.1 Screening of active components and potential targets of the herbal formula

The Chinese names of the herbs Homalomena occulta (Qiannianjian), Angelica dahurica (Baizhi), Phryma leptostachya (Fengxiantougucao), Dipsacus asper (Xuduan), Saposhnikovia divaricata (Fangfeng), Periploca sepium (Xiangjiapi), Artemisia argyi (Aiye), Taxillus chinensis (Sangjisheng), Notopterygium incisum (Qianghuo), Zanthoxylum bungeanum(Huajiao), Angelica biserrata (Duhuo), Carthamus tinctorius (Honghua), Angelica sinensis (Danggui), Paeonia lactiflora (Chishao), Boswellia carterii(Ruxiang), and Commiphora myrrha (Moyao) were entered as keywords into the TCMSP 2.3 database to retrieve their core components and corresponding targets. For Resina Draconis (Xuejie) and Illicium verum (Difengpi), their Chinese names were entered into the HERB database to identify their core components. Subsequently, the InChI Key for each component was obtained and used as a search term in the TCMSP database to retrieve the relevant chemical information. Using the TCMSP database, active components potentially absorbable through the skin were screened based on the following criteria: molecular weight(MW) ≤ 500, octanol-water partition coefficient (AlogP) between 1 and 5, number of hydrogen bond donors (Hdon) ≤ 5, number of hydrogen bond acceptors (Hacc) ≤ 10, and drug-likeness (DL) ≥ 0.18.9 The corresponding targets for these screened components were then identified.

2.2 Acquisition of SPID-related disease targets

The term “sequelae of pelvic inflammatory disease” was used as a keyword to search for potential disease gene targets in the GeneCards database and the Online Mendelian Inheritance in Man (OMIM) database. The obtained targets were subsequently deduplicated, and the union of targets from both databases was compiled for further analysis.

2.3 Prediction of potential targets of huoxue quyu san for the treatment of SPID

The potential targets corresponding to the components of the Huoxue Quyu San formula were imported into the UniProt database for standardized gene name annotation. Targets that could not be annotated were excluded. The remaining targets were then consolidated, and duplicate genes were removed. Subsequently, the Venny 2.1.0 platform was employed to intersect the target genes of Huoxue Quyu San with the target genes associated with SPID, and a Venn diagram was generated. The overlapping genes were identified as the potential therapeutic targets of Huoxue Quyu San for the treatment of SPID. Based on this intersection, the active constituents of Huoxue Quyu San responsible for these therapeutic effects were deduced.

2.4 Construction of the herb-active component-target network

The correspondence between the active components of each herb in Huoxue Quyu San and the drug-disease intersection targets was imported into Cytoscape software (Version 3.10.0) to construct a herbactive component-target network. In this network, different entity types are represented as nodes, and their interrelationships are depicted as edges. The top 5 herbal active components, ranked by their Degree value, were identified as the core components.

2.5 Construction of the PPI network and screening of core targets

The STRING database was used, with the species selected as “Homo sapiens” and a confidence score of 0.4, to construct a PPI network of the disease-drug intersection targets. The file was saved and then imported into Cytoscape 3.10.0 software. The CentiScaPe 2.2 plugin was utilized to calculate three parameters for each gene—degree centrality (DC), betweenness centrality (BC), and closeness centrality (CC)—as well as their medians. Key targets were screened out as those where all parameters were greater than the obtained medians. Subsequently, the size and color of the aforementioned gene nodes were sorted by degree value to plot the core PPI network of Huoxue Quyu San in treating SPID.

2.6 Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of genes and Genomes (KEGG) Pathway enrichment analysis

The common target genes of Huoxue Quyu San and SPID were imported into the Database for Annotation, Visualization and Integrated Discovery (DAVID). The species was restricted to Homo sapiens, and a significance threshold of (P < 0.05) was applied to identify the biological processes and signaling pathways associated with the therapeutic effect of Huoxue Quyu San on SPID. The identified terms were ranked by their -lgP value. The top 10 terms from each of the three Gene Ontology categories—biological process (BP), cellular component (CC), and molecular function (MF)—were selected, along with the top 20 KEGG pathways. The results were visualized using the Bioinformatics Plat-form, generating bar plots for the GO terms and bubble plots for the KEGG pathway enrichment analysis.

2.7 Molecular docking of key active components and core targets

The 2D structure files of the small-molecule ligands corresponding to the top 5 active components by Degree value were downloaded from the PubChem database. Structural optimization of these ligands was performed using Chem3D software (Version 22.0.0). The receptor protein structures for the top 6 core targets by Degree value were obtained from the PDB database. Unrelated small-molecule ligands and water molecules were removed from these receptor structures using PyMOL soft-ware(Version 2.4.0). Molecular docking between the small-molecule ligands and receptor proteins was subsequently conducted using Auto-Dock Vina software (Version 1.5.7) to calculate the binding affinity for each ligand-receptor pair. Finally, the PLIP platform and PyMOL soft-ware were utilized to analyze and visualize selected docking results.

3 Results

3.1 Screening results of active components and potential targets of the herbal formula

A total of 170 active components were identified in Huoxue Quyu San after screening through the HERB and TCMSP databases. The distribution of these components across the individual herbs was as follows:2 from Homalomena occulta (Qiannianjian), 18 from Angelica dahurica(Baizhi), 3 from Phryma leptostachya (Tougucao), 4 from Dipsacus asper(Xuduan), 21 from Saposhnikovia divaricata (Fangfeng), 22 from Periploca sepium (Xiangjiapi), 5 from Artemisia argyi (Aiye), 1 from Taxillus chinensis (Sangjisheng), 16 from Notopterygium incisum (Qianghuo), 4 from Zanthoxylum bungeanum (Huajiao), 8 from Angelica biserrata(Duhuo), 15 from Carthamus tinctorius (Honghua), 3 from Angelica sinensis (Danggui), 9 from Paeonia lactiflora (Chishao), 8 from Boswellia carterii (Ruxiang), 44 from Commiphora myrrha (Moyao), 9 from Illicium verum (Difengpi), and 2 from Resina Draconis (Xuejie). Following annotation using the UniProt database, a total of 253 genes associated with the active components of Huoxue Quyu San were compiled.

3.2 Acquisition results of SPID-related targets

A search for SPID-associated targets was conducted in the GeneCards and OMIM databases. After consolidating the results and taking the union, a total of 2563 potential disease-related targets were identified.

3.3 Drug–disease intersection targets

The 253 gene targets of Huoxue Quyu San were intersected with the SPID-related targets, yielding 154 potential therapeutic targets of Huoxue Quyu San for the treatment of SPID (Fig. 1). Based on these 154 targets, 119 active components of Huoxue Quyu San were deduced. The distribution of these components across the individual herbs was as follows: 1 from Homalomena occulta (Qiannianjian), 16 from Angelica dahurica (Baizhi), 3 from Phryma leptostachya (Tougucao), 2 from Dipsacus asper (Xuduan), 19 from Saposhnikovia divaricata (Fangfeng), 13 from Periploca sepium (Xiangjiapi), 5 from Artemisia argyi (Aiye), 1 from Taxillus chinensis (Sangjisheng), 11 from Notopterygium incisum(Qianghuo), 4 from Zanthoxylum bungeanum (Huajiao), 7 from Angelica biserrata (Duhuo), 12 from Carthamus tinctorius (Honghua), 2 from Angelica sinensis (Danggui), 5 from Paeonia lactiflora (Chishao), 2 from Resina Draconis (Xuejie), 4 from Boswellia carterii (Ruxiang), and 27 from Commiphora myrrha (Moyao).

3.4 Drug-active component-disease target interaction network

A drug-active component-disease target interaction network was constructed using Cytoscape software (Version 3.10.0), as shown in Fig. 2. The network comprised 291 nodes (18 herb nodes, 119 compound nodes, and 154 target nodes) and 1478 edges. Topological analysis performed with the CytoNCA plugin calculated the Degree values for each component. The top 5 active components ranked by Degree value were identified as: quercetin (Degree = 390), apigenin(Degree = 50), baicalein (Degree = 46), luteolin (Degree = 45), and daidzein (Degree = 43). These five active components are predicted to be the core constituents of Huoxue Quyu San responsible for its therapeutic effect on SPID.

3.5 Protein-protein interaction (PPI) network analysis results

In the constructed PPI network, nodes represent proteins and edges represent protein-protein interactions. The network comprised 154 nodes and 7126 edges, with an average node degree of 46.273. A total of 41 target proteins were screened based on having degree centrality, betweenness centrality, and closeness centrality values all exceeding the respective medians (Fig. 3). Among these, the top 6 targets ranked by degree value were identified as core targets: AKT1, TNF, IL-6, INS, IL-1β, and TP53.

3.6 Gene Ontology (GO) and KEGG Pathway enrichment analysis

GO enrichment analysis, encompassing biological processes (BP), cellular components (CC), and molecular functions (MF), is presented in Fig. 4. A total of 626 BP terms, 133 MF terms, and 76 CC terms were identified as significantly enriched (P < 0.05). The enriched BPs primarily included positive regulation of gene expression, response to exogenous stimulus, positive regulation of cell migration, response to hypoxia, and apoptotic processes. Enriched CCs were mainly associated with the extracellular space, protein-containing complex, and external side of the plasma membrane. The principal MFs involved enzyme binding, identical protein binding, protein homodimerization activity, and cytokine activity. KEGG pathway enrichment analysis (Fig. 5) yielded 186 significantly enriched signaling pathways (P < 0.05). In the bubble plot, a larger bubble area indicates a greater number of genes involved in the pathway, while a darker bubble color signifies a higher degree of enrichment. The analysis revealed that the core targets of Huoxue Quyu San in treating SPID are primarily involved in pathways including, but not limited to, Pathways in cancer, the TNF signaling pathway, the PI3K-Akt signaling pathway, the AGE-RAGE signaling pathway in diabetic complications, the IL-17 signaling pathway, Lipid and atherosclerosis, the C-type lectin receptor signaling pathway, and Fluid shear stress and atherosclerosis.

3.7 Molecular docking validation

Molecular docking was performed between the top 5 core active components identified from the drug-active component-disease target network—quercetin, apigenin, baicalein, luteolin, and daidzein—and the top 6 core targets with the highest Degree values in the PPI network—AKT1, TNF, IL-6, INS, IL-1β, and TP53. The lowest binding energy for each ligand-receptor pair was calculated (Table 1). Generally, a binding energy ≤ −5.0 kcal/mol indicates binding activity, while ≤−7.0 kcal/mol suggests strong binding affinity.10 Selected docking poses with strong binding affinities were visualized using the PLIP online tool and PyMOL software (Fig. 6). The results demonstrated that the active components exhibited robust binding activities with the protein targets.

4 Discussion

SPID is not specifically discussed in ancient traditional Chinese medicine texts. Its diagnosis and treatment can be based on pattern differentiation according to its clinical manifestations, such as abdominal pain, abnormal vaginal discharge, infertility, and abdominal masses. According to TCM theory, the pathogenesis of SPID can be differentiated into several patterns, including damp-heat stasis and accumulation, qi stagnation and blood stasis, cold-damp stasis, qi deficiency with blood stasis, and kidney deficiency with blood stasis. However, blood stasis internally is considered the fundamental pathological basis across these patterns. Consequently, activating blood circulation and resolving stasis is established as the core therapeutic principle.11 Huoxue Quyu San is formulated precisely to target the core pathogenesis of qi stagnation and blood stasis in SPID. In its composition, Artemisia argyi (Aiye) serves as the Monarch herb, playing a key role in warming the channels, unblocking collaterals, dispersing cold, and regulating menstruation. Carthamus tinctorius (Honghua), Paeonia lactiflora (Chishao), Angelica sinensis (Danggui), Boswellia carterii(Ruxiang), Commiphora myrrha (Moyao), Resina Draconis (Xuejie), and Illicium verum (Difengpi) act as the Minister herbs, functioning to invigorate blood, move qi, dissipate stasis, and alleviate pain. Homalomena occulta (Qiannianjian), Dipsacus asper (Xuduan), Taxillus chinensis(Sangjisheng), Phryma leptostachya (Tougucao), Periploca sepium(Xiangjiapi), Angelica dahurica (Baizhi), and Saposhnikovia divaricata(Fangfeng) serve as the Assistant herbs, with actions of tonifying the liver and kidneys, and dispelling wind and dampness. Finally, Notopterygium incisum (Qianghuo), Angelica biserrata (Duhuo), and Zanthoxylum bungeanum (Huajiao) act as the Envoy herbs, promoting penetration and unblocking. The entire formula is characterized by a rigorous and balanced composition—warming but not drying, unblocking but not harsh—collectively achieving the effects of moving qi, invigorating blood, and resolving stasis.

As a characteristic TCM external therapy, the hot herbal pack offers several advantages, including simplicity, convenience, low cost, low toxicity, high efficiency, and the ability to deliver the therapeutic action directly to the affected site. The thermal stimulation acts on local acupoints, enhancing the absorption and utilization of the herbal components. This facilitates the functions of moving qi and blood, unblocking the meridians, and treating internal diseases through external application.12 A clinical study on SPID patients13 demonstrated that the TCM hot herbal pack significantly increased the systolic, mean, and diastolic blood flow velocities of the uterine artery, while concurrently reducing serum levels of prostaglandin E2 (PGE2) and substance P. Animal research14 has also shown that hot herbal pack therapy effectively elevates arterial blood flow velocity and decreases levels of high-sensitivity C-reactive protein (hs-CRP), IL-6, IL-12, and TNF-α, providing objective evidence supporting the view that the hot herbal pack improves blood flow conditions and alleviates inflammatory responses. Furthermore, In the clinical management of SPID, although oral antibiotics can control acute infections, their long-term use is prone to causing gut microbiota dysbiosis, hepatorenal dysfunction, and anti-microbial resistance.15 In contrast, Huoxue Quyu San, as a topical Chinese herbal preparation, offers several unique advantages. First, transdermal administration bypasses the first-pass effect of the gastrointestinal tract and liver, thereby reducing systemic adverse effects of the drug.16 Second, the application of heat promotes local blood circulation, enhances drug enrichment and penetration in the pelvic lesion area, and achieves targeted therapy.17 Third, the multi-component synergistic action of the herbal formula better aligns with the complex pathological characteristics of SPID. Fourth, the topical route offers better patient compliance, making it suitable for long-term treatment and rehabilitation management. Therefore, Huoxue Quyu San holds promising clinical application prospects in the comprehensive management of SPID.

This study, through the construction of a “drug-active component-key target” network, identified quercetin, apigenin, baicalein, luteolin, and daidzein as potentially key active constituents of the Huoxue Quyu San Hot Package in the treatment of SPID. These five components are all flavonoids, known for their multiple medicinal activities. Firstly, at the anti-inflammatory level, flavonoids can inhibit the NF-κB signaling pathway, induce Nrf2 activation and HO-1 mRNA expression, and suppress the release of inflammatory cytokines,18 which is crucial for controlling the chronic and persistent inflammatory state of SPID. Secondly, at the antioxidant level, these compounds can mitigate tissue oxidative stress damage resulting from prolonged inflammatory stimulation through multiple mechanisms, including inhibiting ROS production, modulating the PI3K-AKT pathway, and activating the endogenous antioxidant enzyme system.19 More importantly, previous studies have confirmed that certain flavonoids possess biological activity in improving microcirculation.20

Quercetin, widely present in plants, exhibits various biological effects including anti-inflammatory, antiviral, and anti-oxidative stress properties. It inhibits the activation of the NF-κB signaling pathway, thereby reducing the expression of multiple pro-inflammatory factors,21–23 which can suppress the progression of pelvic inflammation. Concurrently, quercetin can inhibit platelet activation, reducing their aggregation and adhesion capabilities to inhibit thrombosis,24 thus improving local pelvic blood circulation. Apigenin possesses anti-inflammatory and antioxidant effects; it can significantly reduce the production of TNF-α, IL-1β, and IL-6, inhibit NF-κB activation, and induce ROS accumulation and lipid peroxidation in endometrial cells, alleviating inflammatory damage and endoplasmic reticulum stress responses.25,26 Additionally, apigenin induces endothelium-dependent vasorelaxation in rats by attenuating oxidative stress and promoting nitric oxide production.27 Through its anti-inflammatory and anti-oxidative stress actions, apigenin may help alleviate SPID. Animal studies28–31 have revealed that baicalein demonstrates significant effects in anti-cancer, anti-inflammation, anti-fungal infections, and preventing oxidative stress. It can act as an anti-inflammatory agent to reduce pro-inflammatory cytokine levels and mitigate inflammatory damage in rats via the PI3K/Akt signaling pathway, thereby relieving pelvic infection and inflammation, showing clear therapeutic effects on pelvic inflammatory disease. Meanwhile, baicalein can activate antioxidant transcriptional programs, inhibit the production of reactive oxygen species (ROS), and alleviate oxidative stress injury.32 Luteolin exhibits functions such as improving microcirculation, anti-inflammation, and anti-infection.33,34 Gu et al.35 found that luteolin inhibits the EGFR/PI3K/AKT/NF-κB and EGFR/ERK/AP-1 signaling pathways, reducing inflammatory factor levels and promoting the production of anti-inflammatory factors, thereby inhibiting M1 macrophage polarization and effectively counteracting inflammatory responses. Daidzein plays an important therapeutic role in anti-inflammation and anti-oxidative stress.36,37 Research38 indicates that daidzein can target and regulate the classical inflammasome pathway, significantly reducing the expression of NLRP3, ASC, and caspase-1, consequently decreasing the maturation and release of pro-inflammatory cytokines such as IL-1β. Daidzein significantly enhances arterial relaxation responses in rats by increasing nitric oxide synthase activity.39 These studies collectively suggest that these active components play significant roles in anti-inflammation, anti-oxidative stress, and regulating microcirculation, which highly align with the pathological mechanisms of SPID.

The Degree value in the PPI network reflects the relevance of protein targets to the therapeutic mechanism. The results indicate that Huoxue Quyu San exerts its therapeutic effects on SPID through central targets including AKT1, TNF, IL-6, INS, IL-1β, and TP53. Among these, IL-1β, TNF, and IL-6 are common pro-inflammatory factors that play crucial roles in mediating the expression of inflammatory cytokines and inflammatory tissue damage. Specifically, IL-1β and IL-6 can promote the production of TNF-α through various pathways.40,41 Studies42,43 have found that serum expression levels of IL-1β, IL-6, and TNF-α are positively correlated with the occurrence and development of pelvic inflammation in rats; pharmacological intervention inhibiting these three pro-inflammatory factors was concurrently associated with observed histopathological improvement in pelvic tissues.

AKT1 is a significant subtype within the PI3K-AKT signaling pathway, exhibiting diverse biological activities in the human body, including but not limited to regulating cellular metabolism, cell proliferation, apoptosis, and inflammatory responses. It is also crucial for regulating vascular endothelial cell function and maintaining vascular integrity.44 The PI3K/Akt pathway can act as an upstream regulatory pathway for NF-κB, mediating pelvic inflammatory responses. In lipopolysaccharide-induced inflammation, the PI3K/Akt signaling pathway achieves anti-inflammatory effects by attenuating the adhesion of monocytes to the vascular endothelium.45,46 INS is the gene encoding insulin. Research47 indicates that a hyperinsulinemic environment promotes the production of pro-inflammatory factors such as IL-1β, IL-6, and TNF-α, activating PI3K/Akt/mTOR/NF-ĸB signaling and leading to accelerated inflammation progression. Furthermore, insulin inhibits cellular autophagy, further exacerbating inflammation. Clinical studies48 have also found that improving insulin resistance can effectively alleviate inflammatory states. The protein p53, encoded by the TP53 gene, possesses composite activities including anti-tumor, anti-inflammatory, cell cycle regulation, and DNA repair functions, participating in various cellular processes.49 Studies50–53 have shown that TP53 can inhibit the expression of the inflammatory factor IL-6, exert anti-inflammatory effects by suppressing the transcriptional process of NF-κB, respond to blood flow shear stress, maintain vascular endothelial homeostasis, and regulate thrombus dissolution and vascular remodeling.

GO analysis revealed that the therapeutic effects of Huoxue Quyu San on SPID involve various biological processes, including positive regulation of gene expression, response to external stimulus, positive regulation of cell migration, response to hypoxia, and apoptotic processes. The associated cellular components include the extracellular space, protein-containing complexes, and the external side of the plasma membrane. The molecular functions involved include enzyme binding, identical protein binding, and protein homodimerization activity.

KEGG enrichment analysis showed that the pathways through which Huoxue Quyu San treats SPID are primarily concentrated in inflammation-related pathways such as the TNF signaling pathway, PI3K-Akt signaling pathway, AGE-RAGE signaling pathway in diabetic complications, C-type lectin receptor signaling pathway, and IL-17 signaling pathway; microcirculation-related pathways such as the Lipid and atherosclerosis pathway and Fluid shear stress and atherosclerosis pathway; and tumor-related pathways such as Pathways in cancer. Among these, the AGE-RAGE pathway is a key driver of inflammation and oxidative stress. It triggers inflammatory responses by generating oxygen radicals, activating NF-κB, and regulating the expression of various inflammatory factors, cytokines, and apoptosis-related genes, such as TNF-α, IL-1β, and IL-6.54 Research by Li et al.55 found that RAGE antagonists can significantly reduce the degree of inflammatory cell infiltration and IL-1β expression levels, thereby alleviating inflammatory damage. IL-17 is an important inflammatory pathway. A study by Garcia, E. M. et al.56 using a human fallopian tube explant model found that IL-17C receptors are expressed on the surface of the human tubal epithelium, and IL-17C is one of the most significantly upregulated genes during tubal inflammation. Animal experiments57 further confirmed that knocking out the IL-17A gene or inhibiting the IL-17 signaling pathway can significantly reduce pathological changes such as hydrosalpinx caused by reproductive tract infections. The C-type lectin receptor signaling pathway is associated with immune recognition. Studies indicate that this pathway continuously exerts pro-inflammatory and pro-fibrotic effects during the post-inflammatory sequelae stage,58 suggesting its potential involvement in maintaining chronic low-grade inflammation in SPID. Thus, it is evident that these pathways can exert specific therapeutic effects in pelvic inflammatory diseases.

Based on the regulatory roles of inflammation-related pathways(such as TNF, PI3K-Akt, and IL-17 signaling pathways), the atherosclerosis pathway, and the C-type lectin receptor signaling pathway reported in relevant studies, combined with the effects of the core targets of Huoxue Quyu San identified in section 2.4, it can be inferred that the active components of Huoxue Quyu San primarily exert therapeutic effects through three regulatory mechanisms: inhibiting inflammation and oxidative stress, improving microcirculation, and inducing apoptosis of abnormal cells. Specifically, this involves potently suppressing inflammatory responses and reducing tissue damage via signaling pathways such as PI3K-Akt/AKT1, TNF, IL-17, AGE-RAGE, and C-type lectin receptors, along with targets including IL-6 and IL-1β; improving pelvic hemorheological properties, protecting vascular endothelial cells, and promoting local pelvic blood circulation by modulating pathways such as fluid shear stress and atherosclerosis and targets including AKT1 and TP53; and inducing apoptosis of abnormal cells through the regulation of targets such as TP53 and CASP3.

The molecular docking results revealed that the binding energies between all core protein targets and active components were below −5.0 kcal/mol, indicating that the key active constituents of Huoxue Quyu San possess a high likelihood of spontaneously binding to the core targets. Notably, the binding energies between IL-6, TNF, and each of the active small molecules were all below −7.0 kcal/mol, suggesting particularly strong binding affinities between these two protein receptors and the ligands.

5 Conclusion

In summary, the Huoxue Quyu San Hot Package exerts its therapeutic effects on SPID through active components such as quercetin, apigenin, baicalein, luteolin, and daidzein, acting on targets including AKT1, TNF, IL-6, INS, IL-1β, and TP53. This involves the modulation of pathways such as the TNF signaling pathway, PI3K-Akt signaling pathway, AGE-RAGE signaling pathway in diabetic complications, IL-17 signaling pathway, and C-type lectin receptor signaling pathway. Through these mechanisms, it alleviates inflammatory responses, reduces oxidative stress, improves hemorheology, exerts anti-infective effects, and regulates endocrine levels, thereby treating SPID. This study elucidates the multi-component, multi-target, and multi-pathway synergistic mechanism of Huoxue Quyu San in treating SPID.

References

[1]

Tan Y. Gynecology of Traditional Chinese Medicine. 4th ed. China Press of Traditional Chinese Medicine; 2016.

[2]

Kreisel K, Torrone E, Bernstein K, Hong J, Gorwitz R. Prevalence of pelvic inflammatory disease in sexually experienced women of reproductive age-united States, 2013-2014. MMWR Morb Mortal Wkly Rep. 2017;66(3):80–83.

[3]

Trent M, Bass D, Ness RB, Haggerty C. Recurrent PID, subsequent STI, and reproductive health outcomes: findings from the PID evaluation and clinical health(PEACH) study. Sex Transm Dis. 2011;38(9):879–881.

[4]

Yeh JM, Hook 3rd EW, Goldie SJ. A refined estimate of the average lifetime cost of pelvic inflammatory disease. Sex Transm Dis. 2003;30(5):369–378.

[5]

Safrai M, Rottenstreich A, Shushan A, Gilad R, Benshushan A, Levin G. Risk factors for recurrent pelvic inflammatory disease. Eur J Obstet Gynecol Reprod Biol. 2020;244:40–44.

[6]

Haggerty CL, Totten PA, Astete SG, et al. Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease. Sex Transm Infect. 2008;84(5):338–342.

[7]

Yin J, Feng M, Xu H. Cai's gynecology chronic pelvic formula with acupuncture alleviates chronic pelvic pain and reduces recurrence in patients with pelvic inflammatory disease sequelae. Am J Transl Res. 2025;17(7):5241–5256.

[8]

Liu YF, Liang XF, Xu LW. Gynecology of Traditional Chinese Medicine. 4th ed. People's Medical Publishing House; 2021.

[9]

Liu Y, Qiu H, Mao DW, et al. Mechanism of Qisui Zhushui Gao applying paste against ascites due to cirrhosis based on network pharmacology and animal experiment. Zhong Cheng Yao. 2024;46(1):298–303.

[10]

Ling XY, Tao JL, Sun X, Yuan B. Exploring material basis and mechanism of Lianhua Qingwen Prescription against coronavirus based on network pharmacology. Zhong Cao Yao. 2020;51(7):1723–1730.

[11]

Wei SB. Thoughts, methods, and long-term management strategies of traditional Chinese medicine in preventing and treating pelvic inflammatory diseases and their sequelae. J Beijing Univ Tradit Chin Med. 2023;46(9):1204–1212.

[12]

Ding MM, Chen WL, Dai YH, Zhang XM. Brief discussion on recent clinical application of traditional Chinese medicine Reyanbao. Jiangxi J Tradit Chin Med.2019;50(8):72–74.

[13]

Qian HY, Xu YY, Zhou QQ. Clinical observation on herbal fomentation combined with microwave in the treatment of sequelae of pelvic inflammatory disease. West J Tradit Chin Med. 2025;38(3):149–154.

[14]

Ren FR, Zhao HF, Zheng XQ, Chen X. Observation on the effect of traditional Chinese medicine hot package in the adjuvant treatment of blood stasis type diabetic foot. Chin J Drug Abuse Prev Treat. 2024;30(2):333–336.

[15]

Urakami T, Matono T. Management of antibiotic adverse events. J Infect Chemother.2025;31(7):102735.

[16]

Baldwin CM, Keating GM. Transdermal oxybutynin. Drugs. 2009;69(3):327–337.

[17]

Hao J, Ghosh P, Li SK, Newman B, Kasting GB, Raney SG. Heat effects on drug delivery across human skin. Expert Opin Drug Deliv. 2016;13(5):755–768.

[18]

Jomova K, Alomar SY, Valko R, et al. Flavonoids and their role in oxidative stress, inflammation, and human diseases. Chem Biol Interact. 2025;413:111489.

[19]

Bas TG. Dietary polyphenols (flavonoids) derived from plants for use in therapeutic health: antioxidant performance, ROS, molecular mechanisms, and bioavailability limitations. Int J Mol Sci. 2026;27(3):1404.

[20]

Macready AL, George TW, Chong MF, et al. Flavonoid-rich fruit and vegetables improve microvascular reactivity and inflammatory status in men at risk of cardiovascular disease–FLAVURS: a randomized controlled trial. Am J Clin Nutr.2014;99(3):479–489.

[21]

Liu T, Li Y, Wang L, et al. Network pharmacology-based exploration identified the antiviral efficacy of Quercetin isolated from mulberry leaves against enterovirus 71 via the NF-κB signaling pathway. Front Pharmacol. 2023;14:1260288.

[22]

Chen X, Zheng L, Zhang B, Deng Z, Li H. Synergistic protection of quercetin and lycopene against oxidative stress via SIRT1-Nox4-ROS axis in HUVEC cells. Curr Res Food Sci. 2022;5:1985–1993.

[23]

Sabetian S, Namavar Jahromi B, Vakili S, et al. Potential effects of soy isoflavones and broccoli extract on oxidative stress, autophagy, and apoptosis gene markers in endometriosis. Int J Fertil Steril. 2024;18(4):384–390.

[24]

Wang W, Li Y, Liu Y, Sun Z, Zhao B, Song F. Quercetin targeted NF-κB to regulate platelet activation and prevent arterial thrombosis. Tissue Cell. 2026;99:103270.

[25]

Chen P, Huo X, Liu W, Li K, Sun Z, Tian J. Apigenin exhibits anti-inflammatory effects in LPS-stimulated BV2 microglia through activating GSK3β/Nrf2 signaling pathway. Immunopharmacol Immunotoxicol. 2020;42(1):9–16.

[26]

Park S, Lim W, Bazer FW, Song G. Apigenin induces ROS-dependent apoptosis and ER stress in human endometriosis cells. J Cell Physiol. 2018;233(4):3055–3065.

[27]

Jin BH, Qian LB, Chen S, et al. Apigenin protects endothelium-dependent relaxation of rat aorta against oxidative stress. Eur J Pharmacol. 2009;616(1–3):200–205.

[28]

Li J, Zhang D, Wang S, et al. Baicalein induces apoptosis by inhibiting the glutamine-mTOR metabolic pathway in lung cancer. J Adv Res. 2025;68:341–357.

[29]

Li L, Lu H, Zhang X, et al. Baicalein acts against candida albicans by targeting eno1 and inhibiting glycolysis. Microbiol Spectr. 2022;10(4):e0208522.

[30]

Bayram P, Aksak Karamese S, Ozdemir B, Salum C, Erol HS, Karamese M. Two flavonoids, baicalein and naringin, are effective as anti-inflammatory and anti-oxidant agents in a rat model of polymicrobial sepsis. Immunopharmacol Immunotoxicol. 2023;45(5):597–606.

[31]

Lv W, Han S, Li K, et al. Baicalein ameliorates DSS-induced ulcerative colitis in mice by inhibiting ferroptosis and regulating gut microbiota. Front Pharmacol. 2025;16:1564783.

[32]

Chi F, Cheng C, Liu K, et al. Baicalein disrupts the KEAP1-NRF2 interaction to alleviate oxidative stress injury by inhibiting M1 macrophage polarization. Free Radic Biol Med. 2025;227:557–569.

[33]

Su J, Xu HT, Yu JJ, et al. Luteolin ameliorates lipopolysaccharide-induced microcirculatory disturbance through inhibiting leukocyte adhesion in rat mesenteric venules. BMC Complement Med Ther. 2021;21(1):33.

[34]

Sun Y, Sun F, Feng W, et al. Luteolin inhibits the biofilm formation and cytotoxicity of methicillin-resistant Staphylococcus aureus via decreasing bacterial toxin synthesis. Evid Based Complement Alternat Med. 2022;2022:4476339.

[35]

Gu M, Pang Z. Luteolin inhibits inflammation and M1 macrophage polarization in the treatment of Pseudomonas aeruginosa-induced acute pneumonia through suppressing EGFR/PI3K/AKT/NF-κB and EGFR/ERK/AP-1 signaling pathways. Phytomedicine. 2025;141:156663.

[36]

Khan AQ, Khan R, Rehman MU, et al. Soy isoflavones (daidzein & genistein) inhibit 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced cutaneous inflammation via modulation of COX-2 and NF-κB in Swiss albino mice. Toxicology. 2012;302(2–3):266–274.

[37]

Kładna A, Berczyński P, Kruk I, Piechowska T, Aboul-Enein HY. Studies on the antioxidant properties of some phytoestrogens. Luminescence. 2016;31(6):1201–1206.

[38]

Márquez-Flores YK, Martínez-Galero E, Correa-Basurto J, et al. Daidzein and equol: ex vivo and in silico approaches targeting COX-2, iNOS, and the canonical inflammasome signaling pathway. Pharmaceuticals. 2024;17(5):647.

[39]

Woodman OL, Missen MA, Boujaoude M. Daidzein and 17 beta-estradiol enhance nitric oxide synthase activity associated with an increase in calmodulin and a decrease in caveolin-1. J Cardiovasc Pharmacol. 2004;44(2):155–163.

[40]

Mori T, Miyamoto T, Yoshida H, et al. IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis. Int Immunol. 2011;23(11):701–712.

[41]

Cabrera-Rivera GL, Madera-Sandoval RL, León-Pedroza JI, et al. Increased TNF-α production in response to IL-6 in patients with systemic inflammation without infection. Clin Exp Immunol. 2022;209(2):225–235.

[42]

Wang Y, Huang Y, Shi L, et al. Shipi Shugan decoction protected against sequela of pelvic inflammatory disease via inhibiting SIRT1/NLRP3 signaling pathway in pelvic inflammatory disease rats. Evid Based Complement Alternat Med. 2022;2022:6382205.

[43]

Zhang B, Yang AT, Wang LN, et al. Anti-inflammatory effects and mechanisms of Podophyllum hexandrum rhizomes and fruits in a chronic pelvic inflammatory disease rat model. J Ethnopharmacol. 2026;357:120954.

[44]

Somanath PR, Razorenova OV, Chen J, Byzova TV. Akt1 in endothelial cell and angiogenesis. Cell Cycle. 2006;5(5):512–518.

[45]

Tang P, Ding Q, Lin J, et al. Pen Yan Jing tablets alleviates pelvic inflammatory disease by inhibiting Akt/NF-κB pathway. Int J Med Sci. 2023;20(11):1386–1398.

[46]

Zhang Y, Li P, Gao Q, Simoncini T, Fu X. 2-Methoxyestradiol prevents monocyte adhesion to vascular endothelial cells via downregulation of VCAM-1 expression. Gynecol Endocrinol. 2016;32(7):571–576.

[47]

Qiao L, Li Y, Sun S. Insulin exacerbates inflammation in fibroblast-like synoviocytes. Inflammation. 2020;43(3):916–936.

[48]

McCoy RG, Irving BA, Soop M, et al. Effect of insulin sensitizer therapy on atherothrombotic and inflammatory profiles associated with insulin resistance. Mayo Clin Proc. 2012;87(6):561–570.

[49]

Hassin O, Oren M. Drugging p53 in cancer: one protein, many targets. Nat Rev Drug Discov. 2023;22(2):127–144.

[50]

Santhanam U, Ray A, Sehgal PB. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc Natl Acad Sci U S A.1991;88(17):7605–7609.

[51]

Komarova EA, Krivokrysenko V, Wang K, et al. p53 is a suppressor of inflammatory response in mice. FASEB J. 2005;19(8):1030–1032.

[52]

Shin J, Hong SG, Choi SY, et al. Flow-induced endothelial mitochondrial remodeling mitigates mitochondrial reactive oxygen species production and promotes mitochondrial DNA integrity in a p53-dependent manner. Redox Biol. 2022;50:102252.

[53]

Mukhopadhyay S, Antalis TM, Nguyen KP, Hoofnagle MH, Sarkar R. Myeloid p53 regulates macrophage polarization and venous thrombus resolution by inflammatory vascular remodeling in mice. Blood. 2017;129(24):3245–3255.

[54]

Zhou M, Zhang Y, Shi L, et al. Activation and modulation of the AGEs-RAGE axis: implications for inflammatory pathologies and therapeutic interventions - a review. Pharmacol Res. 2024;206:107282.

[55]

Li D, Lei C, Zhang S, Zhang S, Liu M, Wu B. Blockade of high mobility group box-1 signaling via the receptor for advanced glycation end-products ameliorates inflammatory damage after acute intracerebral hemorrhage. Neurosci Lett. 2015;609:109–119.

[56]

Garcia EM, Lenz JD, Schaub RE, Hackett KT, Salgado-Pabón W, Dillard JP. IL-17C is a driver of damaging inflammation during Neisseria gonorrhoeae infection of human fallopian tube. Nat Commun. 2024;15(1):3756.

[57]

Armitage CW, Bryan ER, Trim L, et al. Haematopoietic innate interleukin 17A production drives immunopathology in female mouse genital Chlamydia muridarum infection. Scand J Immunol. 2024;99(5):e13359.

[58]

Wang C, Zhang Y, Shen A, et al. Mincle receptor in macrophage and neutrophil contributes to the unresolved inflammation during the transition from acute kidney injury to chronic kidney disease. Front Immunol. 2024;15:1385696.

Rights & permissions

2026 The Authors. Publishing services by Elsevier B.V. on behalf of Higher Education Press and KeAi Communications Co. Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PDF (5586KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉